Denileukin diftitox has promising activity in graft-versus-host disease (GVHD) following haematopoietic stem cell transplantation

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1458, 2004-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft‐versus‐host disease and survival outcome

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 276-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation

By McDonald George B  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1709-1724

Informa Healthcare

Access to resources Recommend Favorite

Vitamins D and K in the Treatment of Osteoporosis Secondary to Graft-versus-host Disease Following Bone-marrow Transplantation

By Hattori M   Morita N   Tsujino Y   Yamamoto M   Tanizawa T  

The Journal of International Medical Research, Vol. 29, Iss. 4, 2001-07 ,pp. : 381-384

Field House Publishing

Access to resources Recommend Favorite

Chronic Graft-Versus-Host Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1974-1986

Bentham Science Publishers

Access to resources Recommend Favorite

Ciclosporin/corticosteroids withdrawal: Membranous glomerulopathy and nephrotic syndrome in a stem cell transplant patient with Graft-versus-host disease, treated with prednisone: case report

By  

Reactions Weekly, Vol. 1, Iss. 1209, 2008-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite